August 30, 2022
Tuesday August, 30 - 1pm-2pm - Auditoire Maisin and on TEAMS
Dr Emily REEVE, Centre for Medicine Use and Safety, Monash University, Australia
Informing implementation of deprescribing into clinical practice: Consumer attitudes towards deprescribing and the role of guidelines
Related papers:
- Weir KR, Ailabouni NJ, Schneider CR, Hilmer SN, Reeve E (2021) “Consumer attitudes towards deprescribing: a systematic review and meta-analysis.” The Journals of Gerontology: Series A (Medical Sciences); Published online 14th Aug 2021.
- Reeve E, Low LF, Hilmer SN (2019) “Attitudes of Older Adults and Caregivers in Australia toward Deprescribing” Journal of the American Geriatrics Society; 67(6):1204-1210.
- Reeve E, Farrell B, Thompson W, Herrmann N, Sketris I, Magin P, Chenoweth L, Gorman M, Quirke L, Bethune G, Hilmer S (2019) “Deprescribing cholinesterase inhibitors and memantine in dementia: guideline summary.” Medical Journal of Australia; 210(4):174-179.
- Reeve E, Anthony AC, Kouladjian O’Donnell L, Low L-F, Ogle, SJ, Glendenning JE, Lorang CEB, Hilmer SN (2018) “Development and pilot testing of the revised Patients’ Attitudes Towards Deprescribing questionnaire for people with cognitive impairment.” Australasian Journal on Ageing; 37(4):E150-4.
Info : anne.spinewine@uclouvain.be